US Patent 8012955 N-substituted-heterocycloalkyloxybenzamide compounds and methods of use
Patent 8012955 was granted and assigned to Rigel Pharmaceuticals on September, 2011 by the United States Patent and Trademark Office.
All edits
Edits on 28 Nov, 2023
Golden AI
Edits made to:
Article (+225 characters)
Article
Patent abstract
The present invention provides N-substituted-heterocycloalkyloxybenzamide compounds, as well as pharmaceutical compositions and methods of use. One embodiment of the invention is a compound having the structure
Edits on 20 Sep, 2023
Golden AI
Edits made to:
Infobox (+6 properties)
Infobox
Patent Inventor Names
Hui Hong1
Ihab S. Darwish1
Jiaxin Yu1
Rajinder Singh1
Sambaiah Thota1
Xiang Xu1
Edits on 20 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 08012955 N-substituted-heterocycloalkyloxybenzamide compounds and methods of use US Patent 8012955 N-substituted-heterocycloalkyloxybenzamide compounds and methods of use
Infobox
Patent Number
080129551
Patent Number
80129551
Edits on 23 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
080129551
Date of Patent
September 6, 2011
1Patent Application Number
119637421
Date Filed
December 21, 2007
1Patent Primary Examiner
Edits on 13 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 08012955 N-substituted-heterocycloalkyloxybenzamide compounds and methods of use
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
08012955
Date of patent
September 6, 2011
Patent application number
11963742
Date Filed
December 21, 2007
Patent primary examiner
Find more entities like US Patent 8012955 N-substituted-heterocycloalkyloxybenzamide compounds and methods of use
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
